Cargando…
Correction: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice
Autores principales: | Overman, Jeroen, Fontaine, Frank, Moustaqil, Mehdi, Mittal, Deepak, Sierecki, Emma, Sacilotto, Natalia, Zuegg, Johannes, Robertson, Avril AB, Holmes, Kelly, Salim, Angela A, Mamidyala, Sreeman, Butler, Mark S, Robinson, Ashley S, Lesieur, Emmanuelle, Johnston, Wayne, Alexandrov, Kirill, Black, Brian L, Hogan, Benjamin M, De Val, Sarah, Capon, Robert J, Carroll, Jason S, Bailey, Timothy L, Koopman, Peter, Jauch, Ralf, Cooper, Matthew A, Gambin, Yann, Francois, Mathias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409503/ https://www.ncbi.nlm.nih.gov/pubmed/37551662 http://dx.doi.org/10.7554/eLife.90408 |
Ejemplares similares
-
Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice
por: Overman, Jeroen, et al.
Publicado: (2017) -
R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma
por: Overman, Jeroen, et al.
Publicado: (2019) -
Homodimerization regulates an endothelial specific signature of the SOX18 transcription factor
por: Moustaqil, Mehdi, et al.
Publicado: (2018) -
Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy
por: Moustaqil, Mehdi, et al.
Publicado: (2020) -
Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach
por: Fontaine, Frank R., et al.
Publicado: (2018)